It has been shown that the decrease in the expression level of GAS5 predicted a poor prognosis of gastric cancer, cervical cancer, and thyroid cancer.20, 21, 22, 23 Research on GAS5 in bladder cancer has gradually increased too. This evidence concerns the gene GAS5 and gastric cancer.